首页|吸入制剂原辅料中无定型物含量检测方法的研究进展

吸入制剂原辅料中无定型物含量检测方法的研究进展

扫码查看
近年来,随着慢性阻塞性肺疾病、哮喘等呼吸系统疾病的多发,肺部给药逐渐成为治疗这些疾病的新趋势,而吸入给药是其中一种应用较多的途径.在吸入制剂的研发过程中,通常会因为微粉化、研磨等工艺而使原料药、辅料和中间体中存在一定量的无定型态物质.无定型态物质的热稳定性较差,在一定条件下容易转变成晶态物质,很可能会引发许多潜在的问题,比如影响最终产品的稳定性等.因此,无论是单一化合物还是依据处方得到的中间体,成熟的药品研发过程必须包括药物中无定型物的检测和定量分析.文章主要对药学领域中无定型物含量的常用检测方法进行系统阐述.
Research Progress on Detection Methods for Amorphous Content in Active Pharmaceutical Ingredients and Excipients of Inhalation Preparations
In recent years,with the frequent occurrence of respiratory diseases such as chronic obstructive pulmonary disease and asthma,pulmonary administration has gradually become a new trend in the treatment of these diseases.And inhalation administration is one of the more widely used ways.In the development of inhalation,there is often a certain amount of amorphous material present in the active pharmaceutical ingredients,excipients,and intermediates due to the processes such as micronization and grinding.Amorphous material has poor thermal stability and can easily transform into the crystalline under certain conditions,which can potentially cause many issues,such as affecting the stability of the final products.Therefore,whether it is a single compound or an intermediate obtained according to a prescription,a mature drug development process must include the detection and quantitative analysis of amorphous material in the drug.This review mainly elaborates on the detection methods commonly used in the pharmaceutical field for the amorphous content.

inhalation preparationamorphismcontentdetection methodquantitative analysis

夏菁、杨玉兰、陈晓东、王晓飞

展开 >

江西中医药大学药学院,江西南昌 330004

上海欧米尼医药科技有限公司,上海 201203

南通市海门长三角药物高等研究院,江苏南通 226133

吸入制剂 无定型 含量 检测方法 定量分析

2024

中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCD
影响因子:0.487
ISSN:1001-8255
年,卷(期):2024.55(2)
  • 41